Depression and anxiety in patients with cancer

By A. Pitman, S. Suleman, N. Hyde, A. Hodgkiss. British medical journal, 2018

757 citations recorded by the source corpus.

Subfields: Oncology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/ca5c17a7230907477a2c310bf0e760c957bfbd9d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Hideo Yasunaga

Citations in the corpus

• Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority (2019, background): “1), but these are not well understood [1], and require further research.”
• Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies (2019, background): “Generally, sertraline and citalopram have the least propensity for interactions with cancer therapy and tend to be well tolerated [92].”
• Risk of Suicide After Cancer Diagnosis in England (2018, background): “Specific cancers may present insidiously with depressed moodandcertain treatments for cancer canalso causedepression through their direct neuropsychiatric effects.(1) Awarenessof thepotential for suchbiological effects, impulsive catastrophic reactions to diagnosis, and incident or worsening depress”